|Articles|October 7, 2014

Almac Expands its UK Commercial Packaging Facility

Almac expands its blister-packaging suite to meet the needs of two Japanese clients.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

PharmTech Weekly Roundup—June 12, 2026

BySusan Haigney

June 12th 2026

Manufacturing Intelligence: How Digital Twins Are Changing Cleanroom Validation

ByJonathon Thompson,Christopher Cole,Richard Jaenisch

June 12th 2026

Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) syndrome

GSK's Momelotinib Pursues Rare VEXAS Syndrome Indication

ByZachary Zubulake

June 12th 2026

Q&A: Tom Sellig on Why Complex Formulations Are Driving CDMO Growth

ByTom Sellig,Zachary Zubulake

June 12th 2026

Transitioning to fully automated assembly lines

Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly Lines

ByJordan Xu

June 11th 2026

Almac Expands its UK Commercial Packaging Facility

Related Content

PharmTech Weekly Roundup—June 12, 2026

Manufacturing Intelligence: How Digital Twins Are Changing Cleanroom Validation

GSK's Momelotinib Pursues Rare VEXAS Syndrome Indication

Q&A: Tom Sellig on Why Complex Formulations Are Driving CDMO Growth

Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly Lines

Trending on Pharmaceutical Technology

EMA Approved 104 Human Medicines in 2025

Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly Lines

GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push

PharmTech Weekly Roundup—June 12, 2026

GSK's Momelotinib Pursues Rare VEXAS Syndrome Indication